Thangavadivel, Shanmugapriya <br/><br/>
Gly101Val BCL2 Mutation: One Step Closer to Understanding Venetoclax Resistance in CLL.  [electronic resource] 

 -  Cancer discovery  03 2019 
 - 320-322 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Comment 
<br/><br/><label>ISSN: </label>2159-8290 
<br/><br/><label>Standard No.: </label>10.1158/2159-8290.CD-19-0029  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents<br/>Bridged Bicyclo Compounds, Heterocyclic<br/>Humans<br/>Leukemia, Lymphocytic, Chronic, B-Cell<br/>Mutation<br/>Patients<br/>Proto-Oncogene Proteins c-bcl-2<br/>Sulfonamides